Eirik Kjelby
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
Journal: Psychiatry research
Published: December 23, 2025
Levels of and changes in psychosis symptoms and clinical insight: Exploring the impact of differential antipsychotic mechanisms.
Journal: Psychiatry research
Published: April 01, 2025
Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.
Journal: Psychological medicine
Published: December 09, 2024
Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study.
Journal: Psychiatry research
Published: April 12, 2024
Reply to a Letter to the Editors From Dr de Souza and colleagues: "Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity".
Journal: Journal of clinical psychopharmacology
Published: December 15, 2023
Risk factors for mortality in patients admitted to a psychiatric acute ward: A prospective cohort study.
Journal: Acta psychiatrica Scandinavica
Published: August 25, 2023
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).
Journal: Journal of clinical psychopharmacology
Published: April 21, 2023
Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study.
Journal: General hospital psychiatry
Published: March 18, 2022
Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial.
Journal: Journal of clinical psychopharmacology
Published: May 03, 2021
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis.
Journal: Schizophrenia research
Published: April 05, 2021
Last Updated: 09/26/2026